• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Mechanisms of leukemogenesis caused by alterations of the structure of transcription factor PEBP2

Research Project

Project/Area Number 09253220
Research Category

Grant-in-Aid for Scientific Research on Priority Areas

Allocation TypeSingle-year Grants
Research InstitutionInstitute for Virus Research, Kyoto University

Principal Investigator

ITO Yoshiaki  Institute for Virus Research, Kyoto University : Professor, ウイルス研究所, 教授 (80004612)

Co-Investigator(Kenkyū-buntansha) MARUYAMA Mitsuo  Institute for Virus Research, Kyoto University : Instructor, ウイルス研究所, 助手 (00212225)
KANNO Tomohiko  Institute for Virus Research, Kyoto University : Instructor, ウイルス研究所, 助手 (10273525)
Project Period (FY) 1994 – 1999
KeywordsRUNX1 / RUNX2 / RUNX3 / AML1 / PEBP2 / FPD-AML / TGF-β / BMP
Research Abstract

Transcription factor PEBP2 is composed of α and β subunits. There are three genes encoding the α subunit, RUNX1/AML1, RUNX2/CBFA1, RUNX3/PEBP2αC.We found that RUNX1 is required for generation of hematopoietic stem cells from endothelial cells. RUNX1 is the most frequent target of chromosome translocations associated with acute leukemia but we found sporadic loss-of-function point mutations without involving chimeric proteins. Later, familial cases of point mutations were reported which are called Familial Patelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD-AML). Mice carrying heterozygously disrupted RUNX1 gene were found to be a good mouse model for FPD-AML.Haploinsufficiency of RUNX1 is being proved to be leukemogenic.
RUNX2 is essential for maturation of chondrocytes and osteoblasts. Haploinsufficiency of RUNX2 causes cleidocranial dysplasia (CCD). We found that RUNX2 is one of the major target of TGF-β/BMP signaling and mutations of RUNX2 impaired the BMP pathway to cause CCD.
We found that RUNX3 was expressed in epithelial cells of gastrointestinal tractand that the disruption of the gene caused hyperplasia of epithelial layer of glandular stomach. Possible involvement of RUNX3 in gastric cancer is being studied.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Sakakura et al.: "Growth inhibition and induction of differentiation of t(8 ; 21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide"Proc.Natl.Acad.Sci.USA. 91. 11723-11727 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Lu et al.: "Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked tanscription factor PEBP2/CBF."Mol.Cell.Biol.. 15. 1651-1661 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Osato et al.: "Biallelic and heterozygous point mutations in the Runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias."Blood. 93. 1817-1824 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kim et al.: "Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains."EMBO J.. 18. 1609-1620 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nagata et al.: "Immunoglobulin motif DNA recognition and heterodimerization for the PEBP2/CBF Runt-domain."Nature Struct.Biol.. 6. 615-619 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Werner et al.: "Runt-domain take the lead in hematopoiesis and osteogenesis."Nature Medicine. 5. 1356-1357 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sakakura et al.: "Growth inhibition and induction of differentiation of t (8 : 21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8 (ETO) -specific antisense oligonucleotide"Proc.Natl.Acad.Sci.USA. 91. 11723-11727 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Lu et al.: "Subcellular localization of the αand βsubunits of the acute myeloid leukemia-linked tanscription factor PEBP2/CBF."Mol.Cell.Biol.. 15. 1651-1661 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Osato et al.: "Biallelic and heterozygous point mutations in the Runt domain of the AML1/PEBP2αβ gene associated with myeloblastic leukemias."Blood. 93. 1817-1824 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kim et al.: "Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains."EMBO J.. 18. 1609-1620 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nagata et al.: "Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains."Nature Struct.Biol.. 6. 615-619 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Werner et al.: "Runt-domain take the lead in hematopoiesis and osteogenesis."Nature Medicine. 5. 1356-1357 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi